Search Results - "Asadipooya, K."

Transient osteoporosis of the hip: review of the literature by Asadipooya, K., Graves, L., Greene, L. W.

“…Transient osteoporosis of the hip (TOH) is a temporary clinical condition of unknown etiology which usually resolves with conservative therapy though may be…”
Get full text

Management of osteoporosis in patients with chronic kidney disease by Abdalbary, M., Sobh, M., Elnagar, S., Elhadedy, M. A., Elshabrawy, N., Abdelsalam, M., Asadipooya, K., Sabry, A., Halawa, A., El-Husseini, A.

“…Patients with CKD have a 4–fivefold higher rate of fractures. The incidence of fractures increases with deterioration of kidney function. The process of…”
Get full text

Evaluation of adipokines, adiponectin, visfatin, and omentin, in uncomplicated type I diabetes patients before and after treatment of diabetic ketoacidosis by Kalantarhormozi, M., Jouyan, N., Asadipooya, K., Nabipour, I., Mirzaei, K.

“…Background Diabetic ketoacidosis (DKA) is potentially a lethal complication of uncontrolled, especially type 1, diabetes. Understanding the mechanisms…”
Get full text

Combination of spironolactone and sitagliptin improves clinical outcomes of outpatients with COVID-19: a prospective cohort study by Davarpanah, M. A., Adatorwovor, R., Mansoori, Y., Ramsheh, F. S. R., Parsa, A., Hajiani, M., Faramarzi, H., Kavuluru, R., Asadipooya, K.

“…Background There are evidences showing that sitagliptin and spironolactone can potentially improve the clinical outcomes of COVID-19 cases. In this…”
Get full text